Clinical trials have demonstrated that both biosimilars match the reference product's quality, safety and efficacy standards.

Bengaluru: A war of words has erupted between Biocon founder Kiran Mazumdar-Shaw and Karnataka Chief Minister Siddaramaiah on ...

Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...

CA Rudramurthy BV is bullish on Biocon and DMart, citing strong technical setups and sectoral promise. Biocon’s breakout from ...

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...

The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...

Biocon founder Kiran Mazumdar Shaw and Karnataka Chief Minister Siddaramaiah debated on X over the safety of Covid-19 ...

Indian biosimilars developer Biocon Biologics, a subsidiary of Biocon Ltd has announced that the European Commission (EC) has ...

The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other ...

The Karnataka CM has suggested that the recent heart attack deaths in Hassan district may be linked to the vaccination drive ...

Biocon founder Kiran Mazumdar-Shaw refutes Karnataka CM's claim linking Covid-19 vaccines to heart attack deaths in Hassan ...

CM Siddaramaiah responds to Biocon chief's vaccine remarks after Hassan deaths; Kiran Mazumdar Shaw calls for truce.